WSI24-289-Case-4
75 y.o. male with metastatic non-small cell lung cancer, on pembrolizumab. Diarrhea.
Colon: erythema, friability. EGD: gastric erythema, otherwise normal
Immune checkpoint inhibitor therapy effect (pembrolizumab) in stomach and colon
May 12, 2025 4:00:00 PM
